---
accession : E-GEOD-12161
platform  : A-AFFY-44
pathway   : TNFa
cells     : human hepatocellular carcinoma cell line HepG2
treatment : 0.5 nM TNFa
effect    : activating
hours     : 12

control   :
    - GSM306132 1
    - GSM306133 1
    - GSM306145 1
perturbed :
    - GSM306134 1
    - GSM306135 1
    - GSM306146 1
...
